Variant report

Variant	rs2624837
Chromosome Location	chr3:50205962-50205963
allele	C/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:25)
CpG islands
(count:0)
Chromatin interactive
region (count:6)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:25 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ZBTB7A	chr3:50205743-50206880	ECC-1	luminal epithelium:	n/a	chr3:50206735-50206743 chr3:50206734-50206742
2	MAZ	chr3:50205805-50206043	Hela-S3	cervix:	n/a	n/a
3	MAX	chr3:50205945-50206145	Hela-S3	cervix:	n/a	n/a
4	SMC3	chr3:50205859-50206026	Hela-S3	cervix:	n/a	n/a
5	POLR2A	chr3:50205683-50207219	HUVEC	blood vessel:	n/a	n/a
6	CHD2	chr3:50205799-50206083	Hela-S3	cervix:	n/a	n/a
7	TCF12	chr3:50205675-50206405	ECC-1	luminal epithelium:	n/a	n/a
8	EP300	chr3:50202587-50206453	ECC-1	luminal epithelium:	n/a	chr3:50204837-50204850
9	TEAD4	chr3:50205774-50206313	ECC-1	luminal epithelium:	n/a	n/a
10	CEBPB	chr3:50205869-50206042	Hela-S3	cervix:	n/a	n/a
11	ESR1	chr3:50205792-50206220	ECC-1	luminal epithelium:	n/a	n/a
12	MAX	chr3:50205700-50206257	ECC-1	luminal epithelium:	n/a	n/a
13	TFAP2C	chr3:50205730-50206272	Hela-S3	cervix:	n/a	n/a
14	EP300	chr3:50205710-50206356	ECC-1	luminal epithelium:	n/a	n/a
15	POLR2A	chr3:50205728-50206001	Hela-S3	cervix:	n/a	n/a
16	POLR2A	chr3:50205899-50206062	HUVEC	blood vessel:	n/a	n/a
17	TCF12	chr3:50202519-50206607	ECC-1	luminal epithelium:	n/a	chr3:50204972-50204982 chr3:50204102-50204112 chr3:50204849-50204859 chr3:50205080-50205089
18	ESR1	chr3:50205795-50206226	ECC-1	luminal epithelium:	n/a	n/a
19	NFIC	chr3:50202557-50206498	ECC-1	luminal epithelium:	n/a	n/a
20	POLR2A	chr3:50205721-50205996	Hela-S3	cervix:	n/a	n/a
21	NFIC	chr3:50205471-50206467	ECC-1	luminal epithelium:	n/a	n/a
22	ZBTB7A	chr3:50205779-50206546	ECC-1	luminal epithelium:	n/a	n/a
23	TCF7L2	chr3:50205836-50206496	Hela-S3	cervix:	n/a	n/a
24	ESR1	chr3:50205801-50206316	ECC-1	luminal epithelium:	n/a	n/a
25	ESR1	chr3:50205758-50206179	ECC-1	luminal epithelium:	n/a	n/a

No data

(count:6 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr3:50203273..50206743-chr3:50207274..50211024,4	MCF-7	breast:
2	chr3:50201604..50203963-chr3:50205181..50207693,2	K562	blood:
3	chr3:50205468..50208057-chr3:50211488..50214653,3	K562	blood:
4	chr3:50193953..50196565-chr3:50203868..50206072,2	MCF-7	breast:
5	chr3:50202263..50203963-chr3:50204980..50207693,2	K562	blood:
6	chr3:50200976..50202928-chr3:50203961..50206728,2	MCF-7	breast:

No data

Variant related genes	Relation type
MIR566	TF binding region
ENSG00000207922	Chromatin interaction
ENSG00000001617	Chromatin interaction

Extended variants
information (count: 64 )
Associated
traits (count: 5 )

rSNPs within LD-proxies of this variant (count:36)

rs_ID	r²[population]
rs10510755	0.95[GIH][hapmap]
rs1061474	0.89[JPT][hapmap]
rs1138536	0.89[JPT][hapmap]
rs12629572	0.86[GIH][hapmap]
rs12631337	0.93[ASN][1000 genomes]
rs1989839	0.86[GIH][hapmap]
rs2073498	0.90[GIH][hapmap]
rs2097247	0.81[AMR][1000 genomes]
rs2236939	0.92[CEU][hapmap];0.91[CHB][hapmap];0.90[CHD][hapmap];0.90[GIH][hapmap];1.00[MEX][hapmap];0.91[AMR][1000 genomes];0.88[EUR][1000 genomes]
rs2301639	0.95[GIH][hapmap]
rs2526383	0.84[EUR][1000 genomes]
rs2526392	1.00[ASW][hapmap];1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];1.00[LWK][hapmap];1.00[MEX][hapmap];1.00[MKK][hapmap];0.88[TSI][hapmap];1.00[YRI][hapmap];0.87[AFR][1000 genomes];1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs2526393	1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.84[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs2526394	1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];0.88[TSI][hapmap]
rs2526395	1.00[ASW][hapmap];1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];1.00[LWK][hapmap];1.00[MEX][hapmap];1.00[MKK][hapmap];0.88[TSI][hapmap];0.89[YRI][hapmap];0.86[AFR][1000 genomes];1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs2526396	1.00[ASW][hapmap];1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];1.00[LWK][hapmap];1.00[MEX][hapmap];1.00[MKK][hapmap];0.88[TSI][hapmap];0.89[YRI][hapmap];0.86[AFR][1000 genomes];1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs2526400	0.82[AMR][1000 genomes];0.92[EUR][1000 genomes];0.99[ASN][1000 genomes]
rs2624826	0.89[JPT][hapmap]
rs2624836	0.93[AFR][1000 genomes];1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs2624840	0.86[AFR][1000 genomes];0.97[AMR][1000 genomes];0.98[EUR][1000 genomes];0.94[ASN][1000 genomes]
rs2624842	0.85[CEU][hapmap];0.91[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];0.86[MEX][hapmap];0.99[ASN][1000 genomes]
rs28365992	0.90[GIH][hapmap]
rs2856237	0.89[JPT][hapmap]
rs2856238	0.89[JPT][hapmap]
rs2859580	0.86[EUR][1000 genomes];0.82[ASN][1000 genomes]
rs3806708	0.90[GIH][hapmap]
rs57319506	0.81[AMR][1000 genomes]
rs57462170	0.94[AMR][1000 genomes];0.86[EUR][1000 genomes];0.91[ASN][1000 genomes]
rs57842657	0.91[AMR][1000 genomes];0.94[EUR][1000 genomes];0.97[ASN][1000 genomes]
rs58051625	0.81[AMR][1000 genomes]
rs6446201	0.86[AMR][1000 genomes];0.87[EUR][1000 genomes];0.97[ASN][1000 genomes]
rs6446202	1.00[CEU][hapmap];0.83[CHB][hapmap];0.89[EUR][1000 genomes];0.87[ASN][1000 genomes]
rs6776145	0.86[GIH][hapmap];0.83[TSI][hapmap]
rs739431	0.85[CEU][hapmap];0.91[CHB][hapmap];0.90[CHD][hapmap]
rs7642692	1.00[CEU][hapmap];0.83[CHB][hapmap];0.95[CHD][hapmap];0.83[TSI][hapmap];0.96[EUR][1000 genomes];0.86[ASN][1000 genomes]
rs9831967	0.80[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:28 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv834690	chr3:50101835-50267584	Strong transcription Weak transcription Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	24 gene(s)	inside rSNPs	diseases
2	nsv515986	chr3:50104307-50267584	Bivalent Enhancer Strong transcription Weak transcription Flanking Bivalent TSS/Enh Active TSS Enhancers Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	24 gene(s)	inside rSNPs	diseases
3	nsv432418	chr3:50114496-50224196	Bivalent Enhancer Transcr. at gene 5' and 3' Genic enhancers Weak transcription Strong transcription Flanking Active TSS Enhancers Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	18 gene(s)	inside rSNPs	diseases
4	nsv1001775	chr3:50129479-50311666	Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Strong transcription Weak transcription Transcr. at gene 5' and 3' Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	42 gene(s)	inside rSNPs	diseases
5	nsv876768	chr3:50144951-50267584	Bivalent/Poised TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription Bivalent Enhancer Strong transcription Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	17 gene(s)	inside rSNPs	diseases
6	nsv523662	chr3:50144951-50584999	Flanking Bivalent TSS/Enh Weak transcription Genic enhancers Bivalent Enhancer Strong transcription Transcr. at gene 5' and 3' Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	101 gene(s)	inside rSNPs	diseases
7	nsv1013949	chr3:50151712-50339163	Flanking Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Active TSS Bivalent Enhancer Genic enhancers Strong transcription Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
8	nsv590250	chr3:50153356-50332697	Weak transcription Enhancers Strong transcription Flanking Active TSS Genic enhancers Bivalent/Poised TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	43 gene(s)	inside rSNPs	diseases
9	nsv876769	chr3:50155468-50408398	Active TSS Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent/Poised TSS Strong transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	94 gene(s)	inside rSNPs	diseases
10	esv1821728	chr3:50156142-50657253	Strong transcription Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	109 gene(s)	inside rSNPs	diseases
11	esv1793751	chr3:50157364-50476363	Weak transcription Enhancers Transcr. at gene 5' and 3' Strong transcription Flanking Bivalent TSS/Enh Genic enhancers Flanking Active TSS Active TSS Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	98 gene(s)	inside rSNPs	diseases
12	esv1828162	chr3:50157364-50506151	Enhancers Genic enhancers Transcr. at gene 5' and 3' Flanking Active TSS Active TSS Weak transcription Strong transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	98 gene(s)	inside rSNPs	diseases
13	nsv590251	chr3:50158774-50337422	Active TSS Strong transcription Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
14	nsv470561	chr3:50158774-50584999	Flanking Active TSS Enhancers Weak transcription Genic enhancers Active TSS Bivalent Enhancer Strong transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	99 gene(s)	inside rSNPs	diseases
15	nsv876770	chr3:50158774-50609624	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Strong transcription Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	103 gene(s)	inside rSNPs	diseases
16	nsv523560	chr3:50172397-50339163	Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Genic enhancers Strong transcription Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
17	nsv460529	chr3:50178011-50324672	Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' Genic enhancers Strong transcription Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
18	nsv460530	chr3:50178011-50324672	Bivalent Enhancer Weak transcription Flanking Active TSS Enhancers Strong transcription Active TSS Transcr. at gene 5' and 3' Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
19	nsv590252	chr3:50178011-50324672	Enhancers Bivalent Enhancer Strong transcription Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
20	nsv1002916	chr3:50187646-50311666	Enhancers Flanking Bivalent TSS/Enh Weak transcription Strong transcription Flanking Active TSS Genic enhancers Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
21	nsv536564	chr3:50187646-50311666	Flanking Active TSS Enhancers Weak transcription Strong transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
22	nsv1014256	chr3:50187646-50339163	Enhancers Active TSS Strong transcription Weak transcription Genic enhancers Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
23	nsv536565	chr3:50187646-50339163	Flanking Active TSS Bivalent Enhancer Active TSS Strong transcription Enhancers Weak transcription Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
24	nsv1001993	chr3:50187646-50640808	Weak transcription Enhancers Flanking Active TSS Active TSS Genic enhancers Bivalent/Poised TSS Bivalent Enhancer Strong transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	104 gene(s)	inside rSNPs	diseases
25	nsv590253	chr3:50196418-50337422	Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Genic enhancers Transcr. at gene 5' and 3' Active TSS Enhancers Strong transcription Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
26	esv2757870	chr3:50198478-50371377	Genic enhancers Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Active TSS Bivalent/Poised TSS Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	74 gene(s)	inside rSNPs	diseases
27	esv2759148	chr3:50198478-50371377	Enhancers Weak transcription Genic enhancers Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Strong transcription Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	74 gene(s)	inside rSNPs	diseases
28	nsv834692	chr3:50198485-50393464	Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Genic enhancers Bivalent Enhancer Active TSS Transcr. at gene 5' and 3' Strong transcription Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	94 gene(s)	inside rSNPs	diseases

mRNA abundance (count:5)

SNP	Gene	Cis/trans	Tissue	Source
rs2624837	ARIH2	cis	cerebellum	SCAN
rs2624837	SLC25A20	cis	cerebellum	SCAN
rs2624837	DALRD3	cis	parietal	SCAN
rs2624837	SFMBT1	cis	parietal	SCAN
rs2624837	NEK4	cis	parietal	SCAN

Chromatin state (count:94 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:50194200-50208800	Weak transcription	Pancreas	Pancrea
2	chr3:50194800-50207600	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
3	chr3:50195400-50210200	Genic enhancers	Fetal Stomach	stomach
4	chr3:50195400-50210600	Enhancers	Left Ventricle	heart
5	chr3:50195400-50210800	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
6	chr3:50196200-50211600	Enhancers	Rectal Mucosa Donor 31	rectum
7	chr3:50197200-50211600	Genic enhancers	Esophagus	oesophagus
8	chr3:50197800-50207600	Enhancers	Colonic Mucosa	Colon
9	chr3:50198600-50206400	Enhancers	Gastric	stomach
10	chr3:50199200-50209400	Enhancers	Placenta	Placenta
11	chr3:50199400-50206400	Enhancers	NHLF	lung
12	chr3:50200000-50206600	Enhancers	Cortex derived primary cultured neurospheres	brain
13	chr3:50200000-50209600	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
14	chr3:50200000-50210400	Enhancers	Fetal Brain Male	brain
15	chr3:50200600-50206000	Enhancers	Fetal Intestine Large	intestine
16	chr3:50200600-50211800	Enhancers	Right Ventricle	heart
17	chr3:50201200-50206200	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
18	chr3:50201200-50206600	Enhancers	Ovary	ovary
19	chr3:50201800-50207400	Enhancers	Brain Hippocampus Middle	brain
20	chr3:50202000-50207200	Enhancers	Small Intestine	intestine
21	chr3:50202000-50210600	Enhancers	A549	lung
22	chr3:50202200-50206200	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
23	chr3:50202200-50210400	Enhancers	Lung	lung
24	chr3:50202400-50206400	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
25	chr3:50202400-50208800	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
26	chr3:50202800-50206800	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
27	chr3:50202800-50206800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
28	chr3:50202800-50207200	Enhancers	Fetal Lung	lung
29	chr3:50202800-50211000	Enhancers	Fetal Muscle Leg	muscle
30	chr3:50203000-50210000	Enhancers	Duodenum Mucosa	Duodenum
31	chr3:50203400-50206400	Enhancers	Osteobl	bone
32	chr3:50203400-50206600	Enhancers	Breast Myoepithelial Primary Cells	Breast
33	chr3:50203400-50211400	Weak transcription	Placenta Amnion	Placenta Amnion
34	chr3:50203600-50206400	Genic enhancers	Fetal Intestine Small	intestine
35	chr3:50203600-50207000	Genic enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
36	chr3:50203800-50206400	Enhancers	Brain Inferior Temporal Lobe	brain
37	chr3:50203800-50210000	Genic enhancers	HMEC	breast
38	chr3:50204000-50206400	Enhancers	Brain Germinal Matrix	brain
39	chr3:50204000-50207200	Enhancers	Colon Smooth Muscle	Colon
40	chr3:50204000-50208200	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
41	chr3:50204000-50208200	Weak transcription	Fetal Heart	heart
42	chr3:50204000-50208400	Weak transcription	Primary hematopoietic stem cells	blood
43	chr3:50204000-50208800	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
44	chr3:50204200-50206600	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
45	chr3:50204200-50207800	Enhancers	Adipose Nuclei	Adipose
46	chr3:50204200-50208200	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
47	chr3:50204200-50208200	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
48	chr3:50204200-50208400	Enhancers	Skeletal Muscle Female	skeletal muscle
49	chr3:50204400-50206000	Weak transcription	Brain Substantia Nigra	brain
50	chr3:50204400-50211000	Weak transcription	H9 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links